Beginning Cash: The amount of cash reported by the company on its previous statement.
MIRA Pharmaceuticals, Inc. (MIRA) had Beginning Cash of $6.35M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-1.21M |
|
-- |
|
-- |
|
$1.16M |
|
$-1.16M |
|
$-0.05M |
|
$-1.21M |
|
$-1.21M |
|
$-1.21M |
|
$-1.21M |
|
$-1.21M |
|
$-1.21M |
|
$-1.16M |
|
$-1.16M |
|
42.02M |
|
42.02M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$8.17M |
|
-- |
|
$0.04M |
|
$8.20M |
|
$0.04M |
|
-- |
|
-- |
|
$0.04M |
|
$8.16M |
|
$8.16M |
|
$8.16M |
|
42.02M |
|
| Cash Flow Statement Financials | |
$-2.41M |
|
-- |
|
$-0.33M |
|
|
Beginning Cash |
$6.35M |
$3.61M |
|
$-2.74M |
|
$0.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
200.08 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.41M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.81% |
|
-14.81% |
|
-14.73% |
|
-14.81% |
|
$0.19 |
|
$-0.06 |
|
$-0.06 |
|